Impaired dacarbazine activation and 7-ethoxyresorufin deethylation in vitro by polymorphic variants of CYP1A1 and CYP1A2: implications for cancer therapy.

Benjamin Lewis, Porntipa Korprasertthaworn, John Miners

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Impaired dacarbazine activation and 7-ethoxyresorufin deethylation in vitro by polymorphic variants of CYP1A1 and CYP1A2: implications for cancer therapy.'. Together they form a unique fingerprint.

    Medicine & Life Sciences